We are live on ! Find out more
HCM

Highbridge Capital Management Portfolio holdings

AUM $3.09B
1-Year Est. Return 31.19%
This Fund
S&P 500
This Quarter Est. Return
+1.47%
1 Year Est. Return
+31.19%
3 Year Est. Return
+54.53%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.39%
AUM
$5.61B
AUM Growth
-$1.08B
Cap. Flow
-$1.6B
Cap. Flow %
-28.46%
Top 10 Hldgs %
18.58%
Holding
2,227
New
741
Increased
343
Reduced
424
Closed
642

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 7.69%
2 Technology 7.38%
3 Healthcare 6.49%
4 Industrials 5.41%
5 Communication Services 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENV
301
DELISTED
ENVESTNET, INC.
ENV
$3.04M 0.05%
+61,039
New +$3.16M
EPC icon
302
Edgewell Personal Care
EPC
$1.25B
$3.03M 0.05%
+51,048
New +$3.21M
RCL icon
303
Royal Caribbean
RCL
$85.1B
$2.98M 0.05%
25,000
-65,000
-72% -$8.04M
CONE
304
DELISTED
CyrusOne Inc Common Stock
CONE
$2.97M 0.05%
49,858
-44,053
-47% -$2.67M
BKNG icon
305
CALL
Booking.com
BKNG
$149B
$2.96M 0.05%
+42,500
New +$3.08M
BKNG icon
306
PUT
Booking.com
BKNG
$149B
$2.96M 0.05%
+42,500
New +$3.08M
TWLO icon
307
Twilio
TWLO
$30B
$2.89M 0.05%
+122,643
New +$3.44M
DIS icon
308
Walt Disney
DIS
$167B
$2.84M 0.05%
+26,451
New +$2.72M
SLM icon
309
SLM Corp
SLM
$4.89B
$2.84M 0.05%
+251,742
New +$2.76M
B
310
CALL
Barrick Mining
B
$61.5B
$2.83M 0.05%
+195,200
New +$2.88M
PDS
311
Precision Drilling
PDS
$999M
$2.74M 0.05%
45,000
-30,000
-40% -$1.64M
ABEOW
312
DELISTED
Abeona Therapeutics Inc Warrant
ABEOW
$2.73M 0.05%
250,000
SJM icon
313
PUT
J.M. Smucker
SJM
$12.7B
$2.67M 0.05%
21,500
+2,000
+10% +$222K
OLLI icon
314
Ollie's Bargain Outlet
OLLI
$4.44B
$2.66M 0.05%
+50,000
New +$2.36M
GCVRZ
315
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$2.66M 0.05%
7,013,595
+2,497,879
+55% +$948K
HA
316
DELISTED
Hawaiian Holdings, Inc.
HA
$2.65M 0.05%
66,636
-2,660
-4% -$102K
MKSI icon
317
MKS Inc
MKSI
$20.1B
$2.63M 0.05%
27,800
+25,062
+915% +$2.5M
AVGO icon
318
Broadcom
AVGO
$1.85T
$2.6M 0.05%
101,090
-99,910
-50% -$2.6M
ILG
319
CALL
DELISTED
ILG, Inc Common Stock
ILG
$2.59M 0.05%
90,800
EIGR
320
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2.58M 0.05%
+6,167
New +$2.2M
FLXN
321
DELISTED
Flexion Therapeutics, Inc.
FLXN
$2.5M 0.04%
100,000
+49,177
+97% +$1.2M
ABBV icon
322
PUT
AbbVie
ABBV
$443B
$2.5M 0.04%
25,800
+14,600
+130% +$1.38M
HI
323
DELISTED
Hillenbrand
HI
$2.48M 0.04%
55,533
+40,171
+261% +$1.68M
CI icon
324
Cigna
CI
$73.7B
$2.48M 0.04%
+12,200
New +$2.43M
COTV
325
DELISTED
Cotiviti Holdings, Inc.
COTV
$2.47M 0.04%
76,650
+51,561
+206% +$1.71M

Similar funds

Highbridge Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Highbridge Capital Management held 2,227 positions worth $5.61B, down 16% from $6.68B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Highbridge Capital Management withdrew a net $1.6B in Q4 2017, closing 642 positions and reducing 424 holdings. Its most notable exit was Bank Of America Corporation Ws A, an estimated $64.6M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 7.7% of assets, up from 7.2% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Highbridge Capital Management opened a new position in Electronic Arts worth $32M.

  • Highbridge Capital Management's largest Q4 2017 buy was Electronic Arts: 305,011 shares worth $32M.
  • Highbridge Capital Management added most to Alibaba in Q4 2017, an estimated $45.7M increase.
  • Highbridge Capital Management's biggest Q4 2017 reduction was Amazon, cutting an estimated $33.7M.
  • Highbridge Capital Management fully exited Bank Of America Corporation Ws A in Q4 2017, selling an estimated $64.6M.
  • Highbridge Capital Management's ten largest holdings make up 19% of its $5.61B portfolio in Q4 2017.
  • Highbridge Capital Management opened 741 new positions and closed 642 in Q4 2017.
  • Highbridge Capital Management's portfolio value fell 16% quarter-over-quarter to $5.61B.

Based on Highbridge Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.